Shockwave Medical (SWAV) has released an update to notify the public and investors about a regulation fd disclosure.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
On January 29, 2024, the Company released a press statement that is provided in the current report but is not considered “filed” under Section 18 of the Securities Exchange Act of 1934 and is not subject to its liabilities. Furthermore, the information is not incorporated by reference into any other filings, unless explicitly referenced in those documents.
For further insights into SWAV stock, check out TipRanks’ Stock Analysis page.